AI drug discovery

Roche Pays $55M Upfront to Manifold Bio in $2B+ Deal for AI-Guided Next-Gen Brain Shuttles

3 weeks ago talkbio0Tagged AI drug discovery, BBB, Blood - brain barrier anatomy, Manifold Bio, milestones, Neurological diseases, research, Roche (company), shuttles, therapeutic payloads, upfront payment

Roche; Manifold Bio; blood-brain barrier; BBB shuttles; neurological diseases; AI drug discovery; research deal; upfront payment; milestones; therapeutic payloads

Flagship Pioneering Launches Expedition Medicines to Revolutionize Small-Molecule Drug Discovery with AI

1 month ago talkbio0Tagged AI drug discovery, covalent binding drugs, executive leadership, Expedition Medicines, Flagship, generative design, Lila Sciences, Small Molecule, startup

Flagship Pioneering; Expedition Medicines; AI drug discovery; small molecules; covalent binding drugs; Lila Sciences; biotech startup; generative design; executive leadership

Takeda Expands De Novo Protein Research with Second AI-Driven Collaboration with Nabla Bio

1 month ago talkbio0Tagged AI drug discovery, antibody design, biopharmaceutical innovation, De Novo, JAM, Joint Atomic Model, multi-year collaboration, Nabla Bio, Takeda, therapeutic protein

Takeda; Nabla Bio; de novo protein design; AI drug discovery; Joint Atomic Model (JAM); multi-year collaboration; protein therapeutics; antibody design; biopharmaceutical innovation

NanoPhoria Secures €83.5M Series A for Heart Failure Therapy; AstraZeneca and Algen Ink Up to $555M AI Drug Discovery Pact

2 months ago talkbio0Tagged AI drug discovery, Algen Biotechnologies, AstraZeneca, Clustered Regularly Interspaced Short Palindromic Repeats, Deal Value, gene modulation, Heart failure, Immunology, nano-in-micro delivery, NanoPhoria, NP-MP1, Series A

NanoPhoria; Series A; heart failure; NP-MP1; nano-in-micro delivery; AstraZeneca; Algen Biotechnologies; AI drug discovery; immunology; CRISPR; gene modulation; deal value